GSK Investigational Site

Anyang-si 431-070

0 studies enrolling now · 5 studies all time

What they study most

Arthritis, Rheumatoid, Asthma, Parkinson Disease

Studies at this site

• Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) — Stopped early
• Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma — Completed
• A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects — Completed
• A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease — Completed
• COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis — Completed